LearnSkin

Optimizing Clinical Decision-Making and Competence in JAK Inhibitor Therapy for Vitiligo

Treating Facial Vitiligo in a 32-Year-Old Female

0.25 CME Credits
516 Enrolled
Supported by an independent educational grant from Incyte

Course Overview

Preview what you'll learn in this program

0hr 15min
Duration
0.25
Credits
Oct 2025
Released
Jul 2026
Expires
69% avg
Completion

What You'll Learn

Description:

This case-based microlearning activity highlights the evaluation and management of a 32-year-old female presenting with pigmentary changes around the mouth. Through this scenario, learners will review appropriate treatment selection for facial vitiligo, including consideration of site-specific safety, efficacy, and disease progression.

Learning Objectives:

  • Review key considerations for treatment selection in localized facial vitiligo.
  • Identify the most appropriate topical therapeutic option for vitiligo on sensitive areas such as the face.
  • Discuss factors influencing treatment choice, including disease activity, efficacy, and safety profiles of available agents.

Editors

Accreditation Information

Description:

This case-based microlearning activity highlights the evaluation and management of a 32-year-old female presenting with pigmentary changes around the mouth. Through this scenario, learners will review appropriate treatment selection for facial vitiligo, including consideration of site-specific safety, efficacy, and disease progression.

Target Audience

This activity has been designed to meet the educational needs of clinicians and non-clinicians involved in the care of patients with vitiligo.

Disclosure of Conflicts of Interest

Your CE Source ensures balance, independence, objectivity, and scientific rigor in all our educational programs. In accordance with this policy, Your CE Source identifies conflicts of interest with its instructors, content managers, and other individuals who are in a position to control the content of an activity. Conflicts are resolved by Your CE Source to ensure that all scientific research referred to, reported, or used in a continuing education activity conforms to the generally accepted standards of experimental design, data collection, and analysis. Your CE Source is committed to providing its learners with high-quality activities that promote improvements or quality in health care and not the business interest of a commercial interest.

Name of FacultyReported Financial Relationship

Elizabeth Swanson, MD

Advisory Board: Abbvie, Almirall, Alphyn, Arcutis, Boehringer Ingelheim, Castle, Dermavant, Galderma, Incyte, Johnson and Johnson, Leo, Lilly, Novan, Pfizer, Sanofi-Regeneron, Verrica

Speakers' Bureau: Abbvie, Arcutis, Dermavant, Galderma, Incyte, Johnson and Johnson, Lilly, Pfizer, Sanofi-Regeneron, Verrica

Name of Editor / Scientific ReviewerReported Financial Relationship

James Song, MD

Research Funding: SUN

Advisory Board: Janssen, Castle Bioscience, AbbVie, Novartis, UCB, Eli Lily, Acrutis, Incyte, SUN, Amgen

Speakers Bureau: AbbVie, Novartis, UCB, Eli Lily, Incyte, SUN, Amgen

The content managers reported the following financial relationships with commercial interests whose products or services may be mentioned in this activity:

Name of Content ManagerReported Financial Relationship

James Song, MD

Advisory Board: Janssen, Castle Bioscience, AbbVie, Novartis, UCB, Eli Lily, Acrutis, Incyte, SUN, Amgen

Speakers Bureau: AbbVie, Novartis, UCB, Eli Lily, Incyte, SUN, Amgen

All other faculty, planner and/or content managers have nothing to disclose nor do they have any vested interests or affiliations. All conflicts of interest have been resolved.

MD and NP certificate of credit

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Your CE Source and LearnHealth. Your CE Source is accredited by the ACCME to provide continuing medical education for physicians.Your CE Source designates this enduring material activity for a maximum of 0.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

RN certificate of credit

Your CE Source is an approved provider of continuing nursing education by the California Board of Registered Nursing. Provider approved by California Board of Registered Nursing, Provider #16031 for 0.25 contact hours.

Method of Participation

Participants must 1) read the learning objectives and faculty disclosures, 2) study the educational activity, 3) complete the posttest by recording the best answer to each quiz question, and 4) complete the evaluation form.

A statement of credit will be issued only upon receipt of a completed activity evaluation form and a completed post-test with a score of 70% or better. Statements of credit will be available once the evaluation form is completed.

Disclaimer

The content, views, and opinions presented in this educational activity are those of the faculty/authors and do not necessarily reflect those of Incyte, Your CE Source, and/or LearnHealth. The faculty/authors have disclosed if there is any discussion of published and/or investigational uses of agents that are not indicated by the FDA in their presentations. Before prescribing any medicine, primary references and full prescribing information should be consulted. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. The information presented in this activity is not meant to serve as a guideline for patient management.

Learners are required to adhere to the privacy and confidentiality policy as it relates to the CE activities provided on the Internet. Please see the policy at https://www.yourcesource.org

Contact Information

Your CE Source Logo
Your CE Source Logo

This activity is jointly provided by Your CE Source and LearnHealth.

Questions about CE accreditation or CE certificates related to this course, please contact us via email at [email protected]. For all other questions, please contact [email protected].

✨ Ready to Begin Your Journey? ✨

Enroll now to start the course and unlock all learning materials

Login

Quiz

CME Certificate

0.25 CME Credits

Complete Requirements to Unlock

Finish the post-quiz and course evaluation to receive your certificate

  • Pass post-quiz (0% or higher)

Course Discussion

Join the conversation with fellow learners

Continue Your Learning Journey

Next course in Optimizing Clinical Decision-Making and Competence in JAK Inhibitor Therapy for Vitiligo

Pediatric Vitiligo
Next in Series
Course in series

Clinical Management of Pediatric Vitiligo

This course addresses unique considerations in diagnosing, treating, and managing vitiligo in pediatric populations. Clinicians will explore key differences in disease presentation, treatment safety profiles for children, and evidence-based guidelines for managing vitiligo across various pediatric age groups.

CME
Start Next Course
LearnSkin Logo
All material on this website is protected by copyright. Copyright © LearnHealth Inc. 2026.
This website also contains material copyrighted by 3rd parties.
ABOUT
LEGAL
SUBSCRIBE
To Get Posts Directly In Your Inbox!